Agricultural powerhouse Syngenta Group is moving forward with preparations for a massive stock market debut that could reach $10 billion, according to sources familiar with the company’s plans.
The Switzerland-headquartered corporation, which operates under the ownership of Chinese government entity Sinochem, intends to file for its Hong Kong stock exchange listing during the upcoming second quarter, two knowledgeable insiders revealed to news outlets.
Company officials are targeting a fourth-quarter launch for the actual public stock sale, though they acknowledge that market conditions will ultimately determine the final timeline, the anonymous sources indicated.
Earlier reports suggested the agricultural giant might offer as much as 20% of its total shares during the initial public offering, positioning it among the year’s most significant market debuts globally. However, both the scale and schedule remain flexible based on economic factors.
When contacted for details about prospectus submission dates or specific IPO timing, Syngenta representatives declined to provide concrete information.
“We will continue to assess our capital markets strategies based on market conditions and other relevant factors that are in the best interests of our shareholders,” a company spokesperson stated.
The representative added: “As we always said, we intend to return to the capital market when the time is right.”
Investment banking sources indicate that Syngenta has selected China International Capital Corporation (CICC) alongside Goldman Sachs to spearhead the offering. Additional financial institutions including Bank of America, CITIC Securities, and UBS have reportedly joined the underwriting team.
Several of the named banks either refused to comment or did not respond to inquiries about their involvement in the potential offering.
